Company Representative in the Organizing Committee
Senior Principal Scientist at Sobi, working with External Innovation at RDMA (Research & Development Medical Affairs)
Christina Kaiser
ABOUT SOBI
Sobi is a global biopharma company (presence in 30 countries) with a mission to unlock the potential of breakthrough therapies for people living with rare diseases. We are around 1900 employees with head office in Stockholm and hubs in Basel, Switzerland and Waltham, US.
Who are we?
Why are we getting involved as a sponsor?
Sweden has a long and successful history of research and innovation within the Life Science industry, and it is important that we foster this heritage of which Sobi is an important part. We are supporting BiotechBuilders for providing an important meeting place for Life Science companies in Sweden, enabling contacts for future collaborations.
What challenges and opportunities do we currently see in the industry?
All work within the life science sector ultimately aims at improving people´s health with innovative medicines. Success today requires balancing organic pipeline expansion with strategic M&A (for larger companies), sensible AI implementation, and aligning investments with defensible value sources while balancing pricing pressures and regulatory uncertainty.
What is currently at the top of our company’s agenda?
We identify unmet medical needs and breakthrough innovations and enable access to life saving treatments.